Animal Science 300

Lecture Quiz #2

March 14, 2001

                                                                                                Name­­­­___________________

I. Label the endocrine profiles, then bracket and label the stages of the estrous cycle on the graph below. (12)

 

 

 

 

II. Complete the following with the most appropriate word or phrase. (10)

1.      Cell type(s) which differentiate into luteal cells under the influence of LH.

2.      Vascular mechanism by which PGF2a is transported from the site of synthesis to the corpus luteum.

3.      Steroid hormone which inhibits myometrial contraction.

4.      Secretory phase of the menstrual cycle.

5.      Protein hormone which increases in antral follicles following selection.

III. If cows on days 3, 9, 16, and 0 are treated at the same time with PGF2a, which animals (theoretically) will have synchronized estrous cycles following the single injection treatment?  (3)

What stage of the estrous cycle will the synchronized animals be in 24-48 hours after treatment? 

How is the PGF2a administered?  

IV. T/F.  Answer T for true and F for false. (10)

______1. Late diestrus is characterized by an increase in oxytocin release from the corpus luteum.

______2. Melatonin secretion by the pineal gland is negatively correlated with GnRH release in sheep.

______3. Follicular waves occur throughout the estrous cycle but ovulation is inhibited when circulating progesterone levels are high.

______4. Most antral follicles which achieve dominance eventually undergo atresia.

______5. Stigma formation in the Graafian follicle is facilitated by collagenase from the theca interna.

IV. Check (Ö) the following events which result directly or indirectly from the LH surge: (10)

______1. Cumulus expansion and disruption of cumulus-oocyte junctional complexes.

______2. Progression of the oocyte through Meiosis I and into Meiosis II.

______3. A peak in estradiol production by the Graafian follicle.

______4. Stigma formation and follicular rupture.

______5. Episodic release of PGF2a.